Artia Global Partners LP Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$705.8B
Holdings
50
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (50 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | IM8NINSMED INC | 1,102,212 | $191.8B | 27.18% | Put |
| 2 | ABVXABIVAX SA | 610,647 | $82.3B | 11.67% | Call |
| 3 | ARGXARGENX SE | 64,699 | $54.4B | 7.71% | |
| 4 | LLYELI LILLY & CO | 50,500 | $54.3B | 7.69% | |
| 5 | UGLPROSHARES TR II | 542,119 | $30.1B | 4.26% | Put |
| 6 | SLNOSOLENO THERAPEUTICS INC | 583,698 | $27.0B | 3.83% | Call |
| 7 | VKTXVIKING THERAPEUTICS INC | 719,365 | $25.3B | 3.59% | |
| 8 | TRVITREVI THERAPEUTICS INC | 2,013,602 | $25.2B | 3.57% | |
| 9 | QUREUNIQURE NV | 1,023,539 | $24.5B | 3.47% | |
| 10 | NAMSNEWAMSTERDAM PHARMA COMPANY | 503,936 | $17.7B | 2.50% | |
| 11 | AZNASTRAZENECA PLC | 190,752 | $17.5B | 2.48% | |
| 12 | CDTXCIDARA THERAPEUTICS INC | 70,824 | $15.6B | 2.22% | |
| 13 | EYPTEYEPOINT PHARMACEUTICALS INC | 767,098 | $14.0B | 1.99% | |
| 14 | ISIIONIS PHARMACEUTICALS INC | 144,376 | $11.4B | 1.62% | |
| 15 | DNTHDIANTHUS THERAPEUTICS INC | 205,090 | $8.5B | 1.20% | |
| 16 | RVMDREVOLUTION MEDICINES INC | 104,190 | $8.3B | 1.18% | |
| 17 | DGXQUEST DIAGNOSTICS INC | 40,817 | $7.1B | 1.00% | |
| 18 | ALNYALNYLAM PHARMACEUTICALS INC | 17,400 | $6.9B | 0.98% | |
| 19 | VTYXVENTYX BIOSCIENCES INC | 695,982 | $6.3B | 0.89% | |
| 20 | PVLAPALVELLA THERAPEUTICS INC NE | 59,200 | $6.2B | 0.88% | |
| 21 | MLYSMINERALYS THERAPEUTICS INC | 137,800 | $5.0B | 0.71% | |
| 22 | SIONSIONNA THERAPEUTICS INC | 119,741 | $4.9B | 0.70% | |
| 23 | PALIPALISADE BIO INC | 1,992,367 | $4.7B | 0.66% | |
| 24 | RNAAVIDITY BIOSCIENCES INC | 60,100 | $4.3B | 0.61% | |
| 25 | SRRKSCHOLAR ROCK HLDG CORP | 96,285 | $4.2B | 0.60% | |
| 26 | RAPPRAPPORT THERAPEUTICS INC | 138,508 | $4.2B | 0.60% | |
| 27 | PROKPROKIDNEY CORP | 1,838,411 | $4.1B | 0.58% | |
| 28 | ASNDASCENDIS PHARMA A/S | 17,740 | $3.8B | 0.54% | |
| 29 | ABBVABBVIE INC | 14,500 | $3.3B | 0.47% | |
| 30 | BLTEBELITE BIO INC | 17,989 | $2.9B | 0.41% | |
| 31 | ROIVROIVANT SCIENCES LTD | 129,800 | $2.8B | 0.40% | |
| 32 | OCULOCULAR THERAPEUTIX INC | 226,261 | $2.7B | 0.39% | Call |
| 33 | TVTXTRAVERE THERAPEUTICS INC | 70,700 | $2.7B | 0.38% | |
| 34 | DRUGBRIGHT MINDS BIOSCIENCES INC | 33,407 | $2.6B | 0.37% | |
| 35 | UTHUNITED THERAPEUTICS CORP DEL | 5,000 | $2.4B | 0.35% | |
| 36 | PTGXPROTAGONIST THERAPEUTICS INC | 22,951 | $2.0B | 0.28% | |
| 37 | UPBUPSTREAM BIO INC | 68,653 | $1.9B | 0.26% | |
| 38 | XENEXENON PHARMACEUTICALS INC | 40,000 | $1.8B | 0.25% | |
| 39 | BBIOBRIDGEBIO PHARMA INC | 20,400 | $1.6B | 0.22% | |
| 40 | BTSGBRIGHTSPRING HEALTH SVCS INC | 41,600 | $1.6B | 0.22% | |
| 41 | PEPGPEPGEN INC | 205,324 | $1.3B | 0.19% | |
| 42 | CELCCELCUITY INC | 12,900 | $1.3B | 0.18% | |
| 43 | KNSAKINIKSA PHARMACEUTICALS INTL | 29,200 | $1.2B | 0.17% | |
| 44 | NUVLNUVALENT INC | 8,100 | $814.0M | 0.12% | |
| 45 | AVTXAVALO THERAPEUTICS INC | 41,570 | $754.0M | 0.11% | |
| 46 | PRAXPRAXIS PRECISION MEDICINES I | 2,500 | $736.0M | 0.10% | |
| 47 | ANROALTO NEUROSCIENCE INC | 29,192 | $519.0M | 0.07% | |
| 48 | TENXTENAX THERAPEUTICS INC | 42,080 | $512.0M | 0.07% | |
| 49 | KODKODIAK SCIENCES INC | 17,019 | $475.0M | 0.07% | |
| 50 | LYRALYRA THERAPEUTICS INC | 8,756 | $26.0M | 0.00% |